Together Pharma Ltd (TLV:TGTR)
206.20
0.00 (0.00%)
Sep 23, 2026, 12:45 PM IDT
Together Pharma Revenue
Together Pharma had revenue of 53.88M ILS in the half year ending June 30, 2026, with 6.89% growth. This brings the company's revenue in the last twelve months to 99.94M, down -8.50% year-over-year. In the year 2025, Together Pharma had annual revenue of 109.63M with 14.13% growth.
Revenue (ttm)
99.94M
Revenue Growth
-8.50%
P/S Ratio
0.36
Revenue / Employee
475.89K
Employees
210
Market Cap
35.77M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 109.63M | 13.58M | 14.13% |
| Dec 31, 2024 | 96.05M | 5.05M | 5.55% |
| Dec 31, 2023 | 91.01M | 59.78M | 191.42% |
| Dec 31, 2022 | 31.23M | 19.20M | 159.67% |
| Dec 31, 2021 | 12.03M | 803.00K | 7.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Danel (Adir Yeoshua) | 2.98B |
| Amal Holdings A.D. | 2.25B |
| Rafa Laboratories | 459.86M |
| BrainsWay | 180.82M |
| Identi Healthcare | 12.44M |
| BioLineRx | 4.15M |
| Nextage Therapeutics | 2.51M |
| Merchavia Holdings and Investments | 77.00K |